Aimei Net Income From Continuing Ops from 2010 to 2026

AFJK Stock   48.46  0.62  1.30%   
Aimei Health Net Income From Continuing Ops yearly trend continues to be quite stable with very little volatility. The value of Net Income From Continuing Ops is projected to decrease to about 2 M. From the period between 2010 and 2026, Aimei Health, Net Income From Continuing Ops regression line of its data series had standard deviation of  134,909 and standard deviation of  134,909. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2010-12-31
Previous Quarter
2.3 M
Current Value
M
Quarterly Volatility
134.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Aimei Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aimei Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.9 K, Other Operating Expenses of 1.3 M or Total Operating Expenses of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.06. Aimei financial statements analysis is a perfect complement when working with Aimei Health Valuation or Volatility modules.
Check out the analysis of Aimei Health Correlation against competitors.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Aimei Health Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Aimei Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Aimei Health Technology Stock. Highlighted below are key reports to facilitate an investment decision about Aimei Health Technology Stock:
Check out the analysis of Aimei Health Correlation against competitors.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aimei Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.2
Return On Assets
(0.01)
Understanding Aimei Health Technology requires distinguishing between market price and book value, where the latter reflects Aimei's accounting equity. The concept of intrinsic value - what Aimei Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aimei Health's price substantially above or below its fundamental value.
Understanding that Aimei Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aimei Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aimei Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.